Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises when Lendify, a digital lender and one of Sweden’s largest challengers to the banking sector, reaches a billion valuation in conjunction with new capital raising
Mandate

Vinge advises when Lendify, a digital lender and one of Sweden’s largest challengers to the banking sector, reaches a billion valuation in conjunction with new capital raising

September 10, 2019 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with the procurement of new capital in an investment round in a total amount of approximately SEK 197 million.

The issue occurs to a valuation of Lendify of approximately SEK 1 billion (prior to the investment). The capital is intended to be used for capital adequacy and future liquidity.

Vinge’s team primarily consisted of partner Jonas Johansson together with, among others, associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026